FdaApplication
BLA 125166
Identifiers
- fda_app_no: BLA125166
Properties
| Property | Value |
|---|---|
| applicant_name | Alexion Pharmaceuticals, Inc. |
| application_type | BLA |
| approval_date | 2007-03-16 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SOLIRIS | ECULIZUMAB | 300MG/30ML (10MG/ML) | INJECTABLE;IV (INFUSION) |
1 product